June 6, 2024
Webinar: Innovation in Medicine: Exploring the Potential of human Platelet Lysate
Online
Discover the applications and advancements of human platelet lysate in our upcoming webinar, presented by the European Blood Alliance’s Working Group on Innovation and New Products. Scheduled for June 6 from 13:00 to 14:30 CEST, this session will dive into the significant role that human platelet lysate plays in modern medical practices and research.
The webinar will feature expert insights from leaders in the field, including Ólafur Eysteinn Sigurjónsson, Hendrik Feys, Katharina Schallmoser, Erja Kerkelä, and David Lundy. Topics will cover the standardization of human platelet lysate, regulatory considerations, good manufacturing practices for advanced therapy medicinal product (ATMP) manufacturing, and innovative treatments for hypoxic injuries.
Join us for a series of keynote presentations followed by a panel discussion and an interactive Q&A session where you can pose your questions directly to the experts. Specifically, this event is particularly suited for medical researchers and clinical practitioners (EBA Members), and regulatory affairs professionals who are keen to understand and engage with the latest developments across various medical domains.
Once your registration is approved, you will receive an email confirmation with the link to join the webinar.
Detailed Programme
| 13:00 | Opening
Peter O’Leary, Executive Director European Blood Alliance |
| 13:05 | Introduction
Ólafur Eysteinn Sigurjónsson, Head of Research and Development, Icelandic Blood Bank and Chair of EBA Innovation and New Products Working Group |
| 13:15 | Keynote Presentations |
| Towards standardized human Platelet Lysate
Hendrik Feys, Principal Investigator, Red Cross Flanders |
|
| Regulatory aspects
Katharina Schallmoser, Professor for Transfusion Medicine, Paracelsus Medical University of Salzburg, Austria |
|
| Example of GMP production for ATMP manufacturing
Erja Kerkelä, Development Manager, Finnish Red Cross Blood Service |
|
| Treatment of hypoxic injuries
David Lundy, Associate Professor, Taipei Medical University |
|
| 14:15 | Panel Discussion and Q&A |
| Q&A session, allowing participants to engage directly with the experts | |
| 14:35 | Closing
Ólafur Eysteinn Sigurjónsson, Chair Innovation and New Products Working Group |
